Topic
EIR
Lupin Receives EIR from U.S. FDA for Somerset Facility with VAI Classification
Global pharma major Lupin Limited (Lupin) today announced that it has received the Establishment Inspection Report (EIR) from the United…
Lupin Receives EIR from US FDA for its Nagpur Injectable Facility
The EIR was issued following an inspection of the facility conducted from June 10 to June 13, 2024 Lupin has…
OneSource receives EIR for Bengaluru facility
The report follows a comprehensive inspection of the facility, conducted from November 14 to November 22, 2024 OneSource Specialty Pharma…
Lupin receives EIR from US FDA for its Pithampur Unit-1 facility with VAI Classification
The inspection of the facility was held from September 16 to 27, 2024 Lupin has received the Establishment Inspection Report (EIR)…
Lupin receives EIR from US FDA for Somerset manufacturing facility
The facility was inspected from May 7 to May 17, 2024 Lupin has received the Establishment Inspection Report (EIR) from…